Your browser doesn't support javascript.
loading
An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age.
Poder, Airi; Simurka, Pavol; Li, Ping; Roy-Ghanta, Sumita; Vaughn, David.
Affiliation
  • Poder A; Tartu University Clinics Foundation, Raja 31, Tartu, Estonia. Electronic address: airi@std.ee.
  • Simurka P; Pediatric Department, Faculty Hospital, Trencín University AD, Trencín, Slovakia.
  • Li P; GlaxoSmithKline Vaccines, King of Prussia, PA, USA.
  • Roy-Ghanta S; GlaxoSmithKline Vaccines, King of Prussia, PA, USA.
  • Vaughn D; GlaxoSmithKline Vaccines, King of Prussia, PA, USA.
Vaccine ; 32(9): 1121-9, 2014 Feb 19.
Article in En | MEDLINE | ID: mdl-24252703
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Adjuvants, Immunologic / Influenza, Human Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Adjuvants, Immunologic / Influenza, Human Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Vaccine Year: 2014 Document type: Article Country of publication: